Literature DB >> 7930650

Measurements of proteinase 3 and its complexes with alpha 1-proteinase inhibitor and anti-neutrophil cytoplasm antibodies (ANCA) in plasma.

B Baslund1, J Petersen, H Permin, A Wiik, J Wieslander.   

Abstract

Wegener's granulomatosis (WG) is a systemic vasculitis which is diagnosed on clinicopathological findings. The diagnosis may be aided by the presence of anti-neutrophil cytoplasm antibodies (ANCA). In WG, ANCA are primarily directed to proteinase 3 (PR3), a serine protease of the azurophilic granules of the neutrophilic granulocyte. The main plasma inhibitor of PR3 is alpha 1-proteinase inhibitor (PI). To study if free PR3 or complexes between the enzyme and PI or PR3 and ANCA could be found in the plasma from patients with WG we have developed three ELISA systems for the detection of these complexes and free PR3. In all three assays monoclonal antibodies against PR3 were used as capture antibodies. After incubation with plasma, free PR3 was detected by affinity purified rabbit anti-PR3 followed by alkaline phosphatase-labelled swine anti-rabbit IgG. Serial dilutions of purified PR3 was used as standard. The detection limit was 3 ng/ml. PR3 complexed with PI was measured by rabbit anti-PI antibodies and alkaline phosphatase-labelled swine anti-rabbit IgG. Pre-formed in vitro complexes of PR3/PI in serial dilutions were used as standard. The detection limit of this assay was 1 ng/ml. PR3/IgG-ANCA complexes were detected by alkaline phosphatase labelled goat anti-human IgG. A positive plasma sample in serial dilutions was used as standard. Plasma samples from nine patients with WG, eight patients with fever of infectious origin without evidence of vasculitis and ten healthy donors were examined by these methods. Free PR3 could not be found in any of the plasma samples. PR3/PI complexes were detected in healthy donors at levels between 41-85 ng/ml. All WG patients, both active and inactive, had PR3/PI concentrations above this level, and so had all patients with fever. PR3/IgG-ANCA was found in three of the patients with WG, two being ANCA negative with inactive disease and one was ANCA positive with active disease. Thus, the developed methods can be useful for future studies of the clinical relevance of these complexes in patients with WG and possibly other vasculitides.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7930650     DOI: 10.1016/0022-1759(94)90364-6

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Increased neutrophil membrane expression and plasma level of proteinase 3 in systemic vasculitis are not a consequence of the - 564 A/G promotor polymorphism.

Authors:  M Abdgawad; T Hellmark; L Gunnarsson; K W A Westman; M Segelmark
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

2.  IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis.

Authors:  L S Jeffs; C A Peh; A Nelson; P G Tan; E Davey; K Chappell; G B Perkins; P R Hurtado
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

3.  Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma.

Authors:  A S Lee; J D Finkielman; T Peikert; A M Hummel; M A Viss; G L Jacob; H A Homburger; U Specks
Journal:  Clin Exp Immunol       Date:  2006-10       Impact factor: 4.330

4.  The - 564 A/G polymorphism in the promoter region of the proteinase 3 gene associated with Wegener's granulomatosis does not increase the promoter activity.

Authors:  K Pieters; A Pettersson; U Gullberg; T Hellmark
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

5.  Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission.

Authors:  S Ohlsson; J Wieslander; M Segelmark
Journal:  Clin Exp Immunol       Date:  2003-03       Impact factor: 4.330

6.  Proteinase 3 and prognosis of patients with acute myocardial infarction.

Authors:  Leong L Ng; Sohail Q Khan; Hafid Narayan; Paulene Quinn; Iain B Squire; Joan E Davies
Journal:  Clin Sci (Lond)       Date:  2011-03       Impact factor: 6.124

7.  T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission.

Authors:  W J King; C J Brooks; R Holder; P Hughes; D Adu; C O Savage
Journal:  Clin Exp Immunol       Date:  1998-06       Impact factor: 4.330

8.  Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?

Authors:  B Baslund; M Segelmark; A Wiik; W Szpirt; J Petersen; J Wieslander
Journal:  Clin Exp Immunol       Date:  1995-03       Impact factor: 4.330

Review 9.  Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1).

Authors:  G Fantuzzi; C A Dinarello
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.542

Review 10.  Neutrophil Extracellular Traps in ANCA-Associated Vasculitis.

Authors:  Daniel Söderberg; Mårten Segelmark
Journal:  Front Immunol       Date:  2016-06-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.